J2AZ34 Stock Chart & Stats
R$85.23
-R$0.99(-1.15%)
―
--
Day’s Range― - ―
52-Week RangeR$39.96 - R$91.35
Previous CloseN/A
VolumeN/A
Average Volume (3M)88.00
Market Cap
R$84.07B
Enterprise ValueR$98.06K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)16629.6
Beta-0.35
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding64,914,570
10 Day Avg. Volume7
30 Day Avg. Volume88
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Jazz Pharmaceuticals PLC Unsponsored BDR News
J2AZ34 FAQ
What was Jazz Pharmaceuticals PLC Unsponsored BDR’s price range in the past 12 months?
Jazz Pharmaceuticals PLC Unsponsored BDR lowest stock price was R$39.96 and its highest was R$91.35 in the past 12 months.
What is Jazz Pharmaceuticals PLC Unsponsored BDR’s market cap?
Jazz Pharmaceuticals PLC Unsponsored BDR’s market cap is R$84.07B.
When is Jazz Pharmaceuticals PLC Unsponsored BDR’s upcoming earnings report date?
Jazz Pharmaceuticals PLC Unsponsored BDR’s upcoming earnings report date is Nov 11, 2026 which is in 89 days.
How were Jazz Pharmaceuticals PLC Unsponsored BDR’s earnings last quarter?
Jazz Pharmaceuticals PLC Unsponsored BDR released its earnings results on Aug 03, 2026. The company reported R$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by R$0.001.
Is Jazz Pharmaceuticals PLC Unsponsored BDR overvalued?
According to Wall Street analysts Jazz Pharmaceuticals PLC Unsponsored BDR’s price is currently Undervalued.
Does Jazz Pharmaceuticals PLC Unsponsored BDR pay dividends?
Jazz Pharmaceuticals PLC Unsponsored BDR does not currently pay dividends.
What is Jazz Pharmaceuticals PLC Unsponsored BDR’s EPS estimate?
Jazz Pharmaceuticals PLC Unsponsored BDR’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jazz Pharmaceuticals PLC Unsponsored BDR have?
Jazz Pharmaceuticals PLC Unsponsored BDR has 64,914,570 shares outstanding.
What happened to Jazz Pharmaceuticals PLC Unsponsored BDR’s price movement after its last earnings report?
Jazz Pharmaceuticals PLC Unsponsored BDR reported an EPS of R$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.958%.
Which hedge fund is a major shareholder of Jazz Pharmaceuticals PLC Unsponsored BDR?
Currently, no hedge funds are holding shares in BR:J2AZ34
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ascendis Pharma ADR Unsponsored Brazilian Depositary Receipt Repr 0.0666 ADR
―
Baxter International Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh
―
Biomarin Pharmaceutical Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh
―
Exelixis Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh
―
Neurocrine Biosciences, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh
―